Drug Trial Radar · NCT07751016
A Clinical Study of KH001 for Pulp Preservation and Safety in Deep Dentin Caries
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
36
Planned (sponsor's estimate)
Start
Dec 30, 2026
Primary completion
Jun 30, 2028
Study completion Jun 30, 2028
Sponsor
- Lead sponsor
- Seoul National University Dental HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- HysensBio Co., Ltd
- First posted
- Aug 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Supportive care
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Purpose of this Study is to Evaluate Pulp Preservation and Safety of KH001 in the Administration of Deep Dentin Caries.
Conditions
- Dental Caries
Interventions
KH001Drug
Topical applications of KH001
PlaceboDrug
Topical applications of saline
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pulp preservation effectTime frame: Up to 24 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Seoul National University Dental Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.